Online retail group Boohoo (DEBS) has announced a trading update and board changes emphasising “our turnaround continues at pace”. How does the ‘turnaround’ compare to the valuation at a current 24.7p share price?
Following Tom Winnifrith launching the Great British Takeover stakes prize competition, I noted I would monitor the performance of the leading picks, 'The Takeover 12', until we have a contest winner. After it was initially ‘so far, so bad’, The Takeover 12 remain down after over a month but by slightly less than previously and despite also the FTSE 100 and FTSE All-Share benchmarks slightly worsening since then. The full detail follows...
After the success of this year’s biggest and best ever Sharestock, The Mrs. is hard at work making plans for Sharestock 2027 on September 4. We start with the news this morning that Lucian Miers has agreed to trek over from Yorkshire to join us next year. Yesterday Jim Mellon agreed that he will again abandon his 10 dogs for the day and fly over from the Isle of Man to headline the show. And there are more inked in speakers and thus 51 weeks ahead of the event it is already 15% sold out!
I despair of the younger generation as I discuss the welcome to Wales row. I then look at 2 9/11 PR blunders before considering businesses that are doomed to fail with shareholders losing everything including Mothercare (MTC), Hamak (HMV) and Bluebird Mining (BMV)
In May TekCapital (TEK) was gifted 51% of Vesari for $0 but within 5 weeks had published an “independent” , i.e. paid for report saying that a company with no assets, cash or patented IP was worth $293 million. I agree with Liverpool’s greatest numbers man since Ken Dodd that this is just nonsense on stilts. Evil Banksta opines:
On 24 August 2026 as Skinbiotherapeutics (SBTX) appointed a new interim CFO to replace the hapless Emily Bertram it stated “The Company is in advanced discussions with potential NED candidates and looks forward to updating the market in due course, and is also intending to issue a business update by mid-September which will include further Board updates.”
It can blame Donald Trump as much as it wants but the final demise of Mothercare (MTC) has always been inevitable as I have explained numerous times here. To recap.
Yesterday, Nuburu (US:BURU) filed a form 8K which was issued to fess up that due to a material accounting error in its financial statements for the six months ended 30 June 2026, those accounts could no longer be relied upon and the accounts for the three and six months then ended will need to be restated.
In light of today’s shocking news about the clearly not backdated resignation of Paul Mathieson of Amazing AI I have written to the company’s former auditors Pointon Young. But before then I flag up one matter from Mr. Mathieson’s lawyers in Manilla.
My winnings were not great but I was ahead on the spiv buy trade of Satsuma (SATS) and the cash has arrived in my SIPP. I see no point in holding cash so it has been reinvested this morning.
Just over a week ago we wrote on software and services provider to the international education market group Tribal (TRB) that its interims suggested the shares were a “comfortably in line with current market expectations” Buy from a 63p share price. That followed an initial tip just over a year ago at a 61.5p offer price and there’s now a “Proposed Acquisition by Main Capital Partners” announcement.
Quantum Data Energy (QDE) shares were suspended with effect from 1 May 2026 for its failure to publish its audited accounts for the year ended 31 December 2025 by the 30 April 2026 deadline. The cause of the delay in the publication of the audited accounts was triggered by the unprecedented resignation of Crowe UK on 28 April 2026 in respect of inadequate explanation and documentation received in respect of two transactions connected with Quantum’s £5 million fake news scam fundraise and possible or actual breaches of laws and regulations in relation to those transactions.
I almost admire the chutzpah of Paul Mathieson, the poster boy client of Franke Davies and her pals at the Baker Mckenzie International group, as he strives to bury Amazing AI, now known as XXXX Holdings Ltd without a clue as to where the £1 million raised last September went. And now there is a new twist c/o a newly invented time machine
Private label and contract manufactured cleaning and hygiene products company McBride (MCB) has followed results earlier this week with that CFO Mark Strickland has subsequently “sold 110,000 ordinary shares… for a price of £1.9012 per share. This sale was completed for financial planning purposes”. For their own “financial planning purposes”, should other investors follow?
Today IU look at UK and US base rates, Optibiotix (OPTI), Probiotix (PBC), Skinbiotherapeutics (SBTX), Cirata (CRTA) and the Kelly scandals, Smarter web Company (SWC) and its new cunning plan I am too dumb to understand and, PS, Scancell (SCLP)









